NFKB1 and lung disorder: Ighg1 and Igha, two factors that are associated with the NF-κB signaling pathway, were also significantly augmented in the OVA-induced group, and they were obviously mitigated by the treatment with mogroside V. NF-κB pathway is a promising inflammatory pathway for drug intervention in the treatment of a variety of lung diseases, including asthma (30–32).